MJ

Marius James Mc Nicholas

Active Director Director DIN 11551805
DIN 11551805 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Marius James Mc Nicholas

Marius James Mc Nicholas is a Director at Zydus Hospira Oncology Private Limited (since 2026). The company operates in Pharma.

DIN 11551805
Primary Designation Director
Industry Pharma
First Appointment 23 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Feb 2026

Directorship timeline

Open interactive timeline →
Zydus Hospira Oncology Private Limited
Premium access

Shareholding and investment profile for Marius James Mc Nicholas

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Marius James Mc Nicholas

Marius James Mc Nicholas currently holds 1 directorship: Zydus Hospira Oncology Private Limited (Director, since 23 Feb 2026).

Marius James Mc Nicholas was first appointed on 23 Feb 2026 as Director at Zydus Hospira Oncology Private Limited.

The current boards of Marius James Mc Nicholas's companies include Andrew David Chatfield (Zydus Hospira Oncology Private Limited), Ganesh Narayan Nayak (Zydus Hospira Oncology Private Limited), Nareshkumar Natvarlal Prajapati (Zydus Hospira Oncology Private Limited), Prashant Sharma (Zydus Hospira Oncology Private Limited), Rashminkumar Bipinchandra Shah (Zydus Hospira Oncology Private Limited), Sonya Kakkar (Zydus Hospira Oncology Private Limited), among others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available